200+ peer-reviewed articles and other resources illustrate the utility of microsampling technology for a wide variety of analytes and applications.
The future of specimen collection is simpler, smarter, and more convenient.
In some territories, as listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside those territories, our devices are supplied for research use only (RUO), as referenced in some content included here.
Watch our step-by-step instructional videos, learn how to correctly use our specimen collection devices to collect samples remotely, and review some of our illustrated Instructions For Use.
Independent groups have published their bioanalytical methods using VAMSTM technology. We've examined those methods and summarized important considerations.
A collection of webinars and videos that showcase microsampling.
In some territories, as listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside those territories, our devices are supplied for research use only (RUO), as referenced in some content included here.
[Webinar] The Science of Smarter Sampling. A Novel Sample Preparation Approach of Universal Applicability for Mitra Microsamples
This video shows the hemaPEN® in action for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only.
The Mitra® Microsampler is a specimen collection breakthrough
[Demo] How to properly collect a blood sample using a Mitra® collection kit.
[Webinar] How To Successfully Implement Microsampling and Other Disruptive Technologies
[INTRO] See how VAMS® technology facilitates reduced animal use in research, while lowering costs and improving data
[INTRO] Learn why microsampling is a breakthrough in comfort and emotional safety for children
[Webinar] Advances in Microsampling for In Vivo DMPK Studies
Compare the cost of using microsampling devices to that of conventional collection methods in phase 1, 2, and 3 drug development clinical trials.
Still Have Questions? Contact Us →
The Mitra device, based on VAMS technology has advantages over DBS cards and filter paper in the areas of collection, processing, and bioanalysis. The Mitra device provides the key benefits of working with dried blood, but with a volumetrically accurate, stable dried blood sample that reduces the incidence of reworks.
Over sixty references prove that Mitra devices are compatible with a wide rage of analytes from therapeutic drugs to DNA/RNA to biomarkers. Download our analyte compatibility list to learn more. If you don't see your analyte of interest contact one of our Microsampling Specialists and they'll be able to help.
Initial implementation requires an upfront investment and may disrupt existing workflow, depending on the current processes in place. However, any initial friction is well worth it - Mitra microsampling technology saves money (e.g. no cold-chain shipping), labor (e.g. compatible with typical liquid handling instrumentation), and resources (e.g use non-clinical staff to collect specimens) over time while better allowing for future growth.
Mitra automation solutions are available that allow medium- and high-throughput labs to process hundreds or thousands of samples per day. Contact a Microsampling Specialist to learn more.
All storage recommendations should follow the specific assay’s stability data as it was validated by the laboratory performing the analysis. Most samples can be stored and shipped at room temperature. Your Microsampling Specialist can offer specialized guidance if needed.
Our customers have produced bridging data showing correlations between venous blood draws and fingerstick blood draws, but there is a dependence on the analytical workflow and the compounds to be analyzed. Different analytes are known to circulate differently in venous and capillary blood, so studies will need to be done for each individual analyte and assay.
These resources provide quick insight into the benefits of of blood microsampling as well as a summary of manuscripts featuring the Mitra® microsampling device powered by VAMS™ technology.
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.